[Skip to Content]
[Skip to Content Landing]
Article
December 1992

The Complications of Infective Endocarditis: A Reappraisal in the 1980s

Author Affiliations

From the Heart Institute, Sao Paulo (Brazil) University Medical School.

Arch Intern Med. 1992;152(12):2428-2432. doi:10.1001/archinte.1992.00400240050008
Abstract

Background.—  The frequency of complications of infective endocarditis and their influence on the outcome of the patients changed in the antibiotic era. Therefore, we evaluated the complications in a recent large series of patients with infective endocarditis.

Methods.—  We studied 300 episodes of endocarditis in 287 patients in a tertiary cardiology referral center. Predisposing cardiac conditions were valvular heart disease in 147 episodes, congenital heart disease in 37, other heart diseases in five, and prosthetic heart valves in 69. In 69 episodes, there was no previous heart disease. The infecting microorganisms were streptococci in 147 episodes, Staphylococcus aureus in 59, Staphylococcus epidermidis in 14, gram-negative bacteria in 16, other gram-positive bacteria in eight, and fungi in four. In 52 episodes, blood cultures were negative. Seventy-eight patients (26%) died. Complications were defined as any clinically unfavorable event occurring during treatment.

Results.—  A total of 386 complications occurred in 223 episodes (74%); one complication occurred in 128 episodes (57%), two in 57 (26%), three in 18 (8%), four in 13 (6%), five in three (1%), and six or more in three (1%), The complications were as follows: cardiac, 100 occurrences; neurological, 72; septic, 46; associated with medical treatment, 41; renal, 27; extracranial systemic arterial embolism, 16; septic pulmonary embolism, 26; complications related to surgical treatment, 11; acute prosthetic heart valve insufficiency, six; splenic infarction or abscess, three; cardiac rhythm disturbances, three; and other, 19. The distribution of the complications relative to outcome of the patients revealed that fatality exceeded survival rates for neurologic and septic complications.

Conclusions.—  Complications may be common in patients with infective endocarditis. Cardiac complications were the most common ones, but fatality rates were higher for neurologic and septic complications. Hence, heart failure was replaced by neurologic and septic complications as the leading causes of death in patients with infective endocarditis.(Arch Intern Med. 1992;152:2428-2432)

References
1.
Petersdorf RG, Goldman PL.  Changes in the natural history of bacterial endocarditis .  J Chronic Dis. 1979;32:287-291.Crossref
2.
Wilson WR, Giuliani ER, Danielson GK, Geraci JE.  Management of complications of infective endocarditis .  Mayo Clin Proc. 1982;57:162-170.
3.
Weinstein L.  Life-threatening complications of infective endocarditis and their management .  Arch Intern Med. 1986;146:953-957.Crossref
4.
Snow RM, Cobbs CG.  Treatment of complications of infective endocarditis . In: Kaye D, ed.  Infective Endocarditis . Baltimore, Md: University Park Press; 1976:213-227.
5.
Bain RJI, Glover D, Littler WA, Geddes AM.  The impact of a policy of collaborative management on mortality and morbidity from infective endocarditis .  Int J Cardiol. 1988;19:47-54.Crossref
6.
Pelletier LL Jr, Petersdorf RG.  Infective endocarditis: a review of 125 cases from the University of Washington Hospitals, 1963-72 .  Medicine. 1977;56:287-313.Crossref
7.
Kaye D, ed.  Infective Endocarditis . Baltimore, Md: University Park Press; 1976.
8.
Wilson WR, Nichols DR, Thompson RL, Giuliani ER, Geraci JE.  Infective endocarditis: therapeutic considerations .  Am Heart J. 1980;100:689-704.Crossref
9.
Mansur AJ, Grinberg M, Bellotti G, Jatene AD, Pileggi F.  Infective endocarditis in the 1980s: experience at a heart hospital .  Clin Cardiol . 1990;13:623-630.Crossref
10.
Terpenning MS, Buggy BP, Kaufman CA.  Infective endocarditis: clinical features in- young and elderly patients .  Am J Med. 1987;83:626-634.Crossref
11.
Von Reyn CF, Levy BS, Arbeit RD, Friedland G, Crumpacker CS.  Infective endocarditis: an analysis based on strict case definitions .  Ann Intern Med. 1981;94(pt 1):505-518.
12.
Julander I.  Unfavorable prognostic factors in Staphylococcus aureus septicemia and endocarditis .  Scand J Infect Dis. 1985;17:179-187.
13.
Sussman JI, Baron EJ, Tenenbaum MJ, et al.  Viridans streptococcal endocarditis: clinical, microbiological and echocardiographic correlations .  J Infect Dis. 1986;154:597-603.Crossref
14.
Caputo GM, Archer GL, Calderwood SB, Dinubile MJ, Karchmer AW.  Native valve endocarditis due to coagulase-negative staphylococci .  Am J Med. 1987;83:619-625.Crossref
15.
Calderwood SB, Swinski LA, Karchmer AW, Waternaux CM, Buckley MJ.  Prosthetic valve endocarditis: analysis of factors affecting outcome of therapy .  J Thorac Cardiovasc Surg. 1986;92:776-783.
16.
Cukingnan RA, Carey JS, Wittig JH, Cimochowski GE.  Early valve replacement in active infective endocarditis .  J Thorac Cardiovasc Surg. 1983;85:163-173.
17.
Mansur AJ. Avaliacao da Probabilidade de Obito em Portadores de Endocardite Infecciosa. Sao Paulo, Brazil: University of Sao Paulo; 1987. Thesis.
18.
Garvey GJ, Neu HC.  Infective endocarditis—an evolving disease: a review of endocarditis at the Columbia-Presbyterian Medical Center, 19681973 .  Medicine. 1978;57:105-127.Crossref
19.
Brandenburg RO, Giuliani E, Wilson WR, Geraci JE.  Infective endocarditis: a 25 year overview of diagnosis and therapy .  J Am Coll Cardiol. 1983;1:280-291.Crossref
20.
Hancock EW, Shumway NE, Remington JS.  Valve replacement in active bacterial endocarditis .  J Infect Dis. 1971;123:106-108.Crossref
21.
Hosenpud JD, Greenberg BH  The preoperative evaluation in patients with endocarditis: is cardiac catheterization necessary?  Chest. 1983;84:690-694.Crossref
22.
Salgado AV, Furlan AJ, Keys TF, Nichols TR, Beck GJ.  Neurologic complications of endocarditis: a 12-year experience .  Neurology. 1989;39:173-178.Crossref
23.
Pruitt AA, Rubin RH, Karchmer AW, Duncan GW.  Neurologic complications of bacterial endocarditis .  Medicine. 1978;57:329-343.Crossref
24.
Rabinovich S, Evans J, Smith IM, January LE.  A long term view of bacterial endocarditis: 337 cases 1924 to 1963 .  Ann Intern Med. 1965;63:185-198.Crossref
25.
Baumgartner WA, Miller DC, Reitaz BA, et al.  Surgical treatment of prosthetic valve endocarditis .  Ann Thorac Surg. 1982;35:87-102.Crossref
26.
Robbins MJ, Eisenberg ES, Frishman WH.  Infective endocarditis: a pathophysiologic approach to therapy .  Cardiol Clin. 1987;5:545-562.
27.
Sanabria TJ, Alpert JS, Goldberg R, Pape LA, Cheeseman SH.  Increasing frequency of staphylococcal infective endocarditis: experience at a university hospital, 1981 through 1988 .  Arch Intern Med. 1990;150:1305-1309.Crossref
28.
Lowes JA, Williams G, Tabaqchali S, et al.  Ten years of infective endocarditis at St. Bartholomew's Hospital: analysis of clinical features and treatment in relation to prognosis and mortality .  Lancet. 1980;1:133-136.Crossref
29.
Venezio FR, Westenfelder GO, Cook FV, Emmerman J, Phair JP.  Infective endocarditis in a community hospital .  Arch Intern Med. 1982;142:789-792.Crossref
30.
Terpenning MS, Buggy BP, Kaufman CA.  Hospital-acquired infective endocarditis .  Arch Intern Med. 1988;148:1601-1603.Crossref
31.
Sitzmann JV, Townsend TR, Siler MC, Bartlett JG.  Septic and technical complications of central venous catheterization .  Ann Surg. 1985;202:766-770.Crossref
32.
Sznajder JI, Zveibil FR, Bitterman H, Weiner P, Bursztein S.  Central vein catheterization: failure and complication rates by three percutaneous approaches .  Arch Intern Med. 1986;146:259-261.Crossref
33.
Neugarten J, Baldwin DS.  Glomerulonephritis in bacterial endocarditis .  Am J Med. 1984;77:297-304.Crossref
34.
Korzeniowski O, Sande MA, the National Collaborative Endocarditis Study Group.  Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in non-addicts .  Ann Intern Med. 1982;97:496-503.Crossref
35.
Grinberg M, Yamano JS, Lopes EA, et al.  Aspectos anatomopatologicos da endocardite infecciosa: analise de 80 casos submetidos a necropsia .  Arq Bras Cardiol. 1980;35:403-411.
36.
Nihoyannopoulos P, Oakley CM, Exadactylos N, Ribeiro P, Westaby S, Foale RA.  Duration of symptoms and the effects of a more aggressive surgical policy: two factors affecting prognosis of infective endocarditis .  Eur Heart J. 1985;6:380-390.
37.
Mansur AJ, Grinberg M, Leao PP, Chung CV, Stolf NAG, Pilleggi F.  Extracranial mycotic aneurysms in infective endocarditis .  Clin Cardiol. 1986;9:65-72.Crossref
38.
Dinubile M.  Surgery for addiction-related tricuspid valve endocarditis: caveat emptor .  Am J Med. 1987;82:811-813.Crossref
39.
Middlemost S, Wisenbaugh T, Meyerowitz C, et al.  A case for early surgery in native left-sided endocarditis complicated by heart failure: results in 203 patients .  J Am Coll Cardiol. 1991;18:663-667.Crossref
40.
Neftel KA, Hauser SP, Muller MR.  Inhibition of granulopoiesis in vivo and in vitro by beta lactam antibiotics .  J Infect Dis. 1985;152:90-98.Crossref
41.
Johnson JD, Raff MJ, Barnwell PA, Chung CH.  Splenic abscess complicating infectious endocarditis .  Arch Intern Med. 1983;143:906-912.Crossref
×